MAPT and Alzheimer disease: The authors demonstrated that trazodone induced an AD-mediated reduction in microglial activation, as evidenced by a decrease in the expression of IBA1 and NLRP3 inflammasome and an accumulation of non-phosphorylated tau protein [121].